与药物相关的骨硬化:为什么是大骨?
Sydney Kuehn1, Rafaela Scariot2, Mohammed Elsalanty1
1Department of Medical Anatomical Sciences, College of Osteopathic Medicine of the Pacific, Pomona, CA 91766, USA.
Dentistry journal
|May 26, 2023
概括
与药物相关的下骨硬化 (MRONJ) 是抗吸收药物的罕见但严重并发症. 本综述探讨了为什么大骨与其他骨部位不同,对MRONJ具有独特的敏感性.
科学领域:
- 口腔和牙面部外科手术
- 药理学 药理学是指药理学的学科.
- 骨生物学 骨生物学 骨生物学
背景情况:
- 与药物相关的下骨硬化 (MRONJ) 是抗复苏药物的严重不良影响.
- 尽管药物具有全身性作用,但MRONJ主要影响下巴骨.
- 目前对MRONJ病原和预防策略的理解仍然有限.
研究的目的:
- 为了研究下巴骨对MRONJ的独特易感性.
- 探索MRONJ.的多因素病原性.
- 确定预防和治疗MRONJ的潜在新方向.
主要方法:
- 文献综述和对MRONJ现有研究的综合.
- 分析口腔微环境的独特特征.
- 对骨中的骨代谢与其他骨部位的比较研究.
主要成果:
- 骨独特的解剖学和生理学特征可能使其易患MRONJ.
- 口腔微环境中的特定因素有助于MRONJ的发展.
- 了解这些独特因素对于有针对性的预防和管理至关重要.
结论:
- 骨对MRONJ的明显敏感性需要进一步调查.
- 针对口腔微环境可能为预防MRONJ提供新的策略.
- 对MRONJ多因子病原发生的进一步研究至关重要.
相关概念视频
Osteoclasts in Bone Remodeling
3.1K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.1K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
478
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
478
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
212
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
212
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
410
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
410
Peptic Ulcer Disease IV: Management
120
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
120


